Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|April 7, 2025
The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategiesXiaowen Han, Jiayi Zhang, Weidong Li, et al.
Oncology Reports|October 30, 2020
Intrahepatic metastases may be specific to hepatocellular carcinoma due to the coagulation and fibrinolytic systems (Review)Xuemei Li, Baohong Gu, Bofang Wang, et al.
Molecular Carcinogenesis|June 26, 2024
Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathwaysKewei Song, Chenhui Ma, Ewetse Paul Maswikiti, et al.
Therapeutic Advances in Medical Oncology|June 23, 2025
Successful sphincter preservation and long-term survival in a patient with ultra-low locally advanced rectal cancer treated with photodynamic therapy combined with multimodal treatment: a case report and literature reviewDan Zou, Baohong Gu, Yifan Li, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 14, 2022
Interaction between gut microbiota and tumour chemotherapyLe Liu, Yuping Bai, Lin Xiang, et al.
Frontiers in Surgery|February 6, 2023
Electrohydraulic lithotripsy through endoscopic retrograde cholangiopancreatography combined with SpyGlass in the treatment of complex pancreatic duct stones: A case report and literature reviewWeigao Pu, Chenhui Ma, Bofang Wang, et al.
International Journal of Biological Macromolecules|August 8, 2025
Multi-omic analysis reveals the role of coagulation factor family genes and their predictive value for immune checkpoint inhibitors efficacy in gastric cancerLei Gao, Qinying Han, Chenghui Ma, et al.
International Journal of Biological Sciences|July 22, 2022
TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAURTao Zhang, Bofang Wang, Fei Su, et al.
Frontiers in Immunology|October 31, 2022
Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature reviewYunpeng Wang, Bofang Wang, Lin Xiang, et al.
Frontiers in Immunology|April 28, 2025
Successful triple therapy for advanced synchronous multiple primary esophageal carcinoma with metal stenting, photodynamic and comprehensive systemic therapies-shining light on hope: a case report and literature reviewDan Zou, Ying Yan, Yifan Li, et al.
Pageof 10